Real-time enrollment status for this acute myeloid leukemia with flt3/itd mutation clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 10:48 AM UTC
| NCT Number | NCT06222580 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia With FLT3/ITD Mutation |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Uma Borate |
| Last Updated on CT.gov | May 14, 2026 (May 14, 2026) |
As of August 28, 2026: Clinical trial NCT06222580 is currently recruiting participants. This phase1 study for acute myeloid leukemia with flt3/itd mutation is actively seeking new participants at 4 locations across the United States. The study is sponsored by Uma Borate. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06222580 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06222580 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.